Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
Alíz Szabó(University of Pecs), Balázs Sümegi(University of Szeged)
Cited by 97
Related Papers
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210
PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB
|Investigative Ophthalmology & Visual Science|2019|39